381 related articles for article (PubMed ID: 2446317)
1. Interaction of tachykinins with their receptors studied with cyclic analogues of substance P and neurokinin B.
Ploux O; Lavielle S; Chassaing G; Julien S; Marquet A; d'Orléans-Juste P; Dion S; Regoli D; Beaujouan JC; Bergström L
Proc Natl Acad Sci U S A; 1987 Nov; 84(22):8095-9. PubMed ID: 2446317
[TBL] [Abstract][Full Text] [Related]
2. Tachykinin receptors in smooth muscles: a study with agonists (substance P, neurokinin A) and antagonists.
Mizrahi J; Dion S; D'Orléans-Juste P; Escher E; Drapeau G; Regoli D
Eur J Pharmacol; 1985 Nov; 118(1-2):25-36. PubMed ID: 2417867
[TBL] [Abstract][Full Text] [Related]
3. [3H]neurokinin B and 125I-Bolton Hunter eledoisin label identical tachykinin binding sites in the rat brain.
Bergström L; Torrens Y; Saffroy M; Beaujouan JC; Lavielle S; Chassaing G; Morgat JL; Glowinski J; Marquet A
J Neurochem; 1987 Jan; 48(1):125-33. PubMed ID: 3025361
[TBL] [Abstract][Full Text] [Related]
4. Conformationally constrained tachykinin analogs which are selective ligands for the eledoisin binding site.
Cascieri MA; Chicchi GG; Freidinger RM; Colton CD; Perlow DS; Williams B; Curtis NR; McKnight AT; Maguire JJ; Veber DF
Mol Pharmacol; 1986 Jan; 29(1):34-8. PubMed ID: 2418347
[TBL] [Abstract][Full Text] [Related]
5. Quantitative autoradiographic analysis of the distribution of binding sites for [125I]Bolton Hunter derivatives of eledoisin and substance P in the rat brain.
Beaujouan JC; Torrens Y; Saffroy M; Glowinski J
Neuroscience; 1986 Aug; 18(4):857-75. PubMed ID: 2429231
[TBL] [Abstract][Full Text] [Related]
6. Influence of the amino acids of substance P in the recognition of its receptor: affinities of synthesized SP analogues for the specific 125I-BHSP binding site on rat brain synaptosomes.
Lavielle S; Chassaing G; Julien S; Besseyre J; Marquet A
Neuropeptides; 1986; 7(2):191-200. PubMed ID: 2422581
[TBL] [Abstract][Full Text] [Related]
7. Receptors for substance P and neurokinins. Correlation between binding and biological activities.
Dion S; Drapeau G; Rhaleb NE; D'Orléans-Juste P; Regoli D
Eur J Pharmacol; 1987 Jun; 138(1):125-8. PubMed ID: 3040425
[TBL] [Abstract][Full Text] [Related]
8. Binding characteristics of [125I]Bolton-Hunter [Sar9,Met(O2)11]substance P, a new selective radioligand for the NK1 receptor.
Lew R; Geraghty DP; Drapeau G; Regoli D; Burcher E
Eur J Pharmacol; 1990 Aug; 184(1):97-108. PubMed ID: 1698645
[TBL] [Abstract][Full Text] [Related]
9. Demonstration of two distinct tachykinin receptors in rat brain cortex.
Cascieri MA; Chicchi GG; Liang T
J Biol Chem; 1985 Feb; 260(3):1501-7. PubMed ID: 2578461
[TBL] [Abstract][Full Text] [Related]
10. Radioiodinated substance P, neurokinin A, and eledoisin bind predominantly in NK1 receptors in guinea pig lung.
Geraghty DP; Mussap CJ; Burcher E
Mol Pharmacol; 1992 Jan; 41(1):147-53. PubMed ID: 1370705
[TBL] [Abstract][Full Text] [Related]
11. 125I-BH[Sar9, Met(O2)11]-SP, a new selective ligand for the NK-1 receptor in the central nervous system.
Tousignant C; Guillemette G; Drapeau G; Télémaque S; Dion S; Regoli D
Brain Res; 1990 Aug; 524(2):263-70. PubMed ID: 1705465
[TBL] [Abstract][Full Text] [Related]
12. Tachykinin receptors in the small intestine of the cane toad (Bufo marinus): a radioligand binding and functional study.
Burcher E; Warner FJ
Naunyn Schmiedebergs Arch Pharmacol; 1998 Jun; 357(6):692-700. PubMed ID: 9686947
[TBL] [Abstract][Full Text] [Related]
13. Characterization and autoradiographic localization of multiple tachykinin binding sites in gastrointestinal tract and bladder.
Burcher E; Buck SH; Lovenberg W; O'Donohue TL
J Pharmacol Exp Ther; 1986 Mar; 236(3):819-31. PubMed ID: 2419545
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity studies of heptapeptide derivatives related to substance P, neurokinin A, B and other tachykinins on smooth muscles.
Munekata E; Kubo K; Tanaka H; Osakada F
Peptides; 1987; 8(1):169-73. PubMed ID: 2437548
[TBL] [Abstract][Full Text] [Related]
15. Gastric chief cells possess NK1 receptors which mediate pepsinogen secretion and are regulated by agents that increase cAMP and phospholipase C.
Kitsukawa Y; Turner RJ; Pradhan TK; Jensen RT
Biochim Biophys Acta; 1996 Jun; 1312(2):105-16. PubMed ID: 8672532
[TBL] [Abstract][Full Text] [Related]
16. Binding of a iodinated substance P analog to a NK-1 receptor on isolated cell membranes from rat anterior pituitary.
Larsen PJ; Mikkelsen JD; Saermark T
Endocrinology; 1989 May; 124(5):2548-57. PubMed ID: 2468475
[TBL] [Abstract][Full Text] [Related]
17. Species differences between [3H] substance P binding in rat and guinea-pig shown by the use of peptide agonists and antagonists.
Fardin V; Garret C
Eur J Pharmacol; 1991 Aug; 201(2-3):231-4. PubMed ID: 1724651
[TBL] [Abstract][Full Text] [Related]
18. A new type of tachykinin binding site in the rat brain characterized by specific binding of a labeled eledoisin derivative.
Beaujouan JC; Torrens Y; Viger A; Glowinski J
Mol Pharmacol; 1984 Sep; 26(2):248-54. PubMed ID: 6207421
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological receptors for substance P and neurokinins.
Regoli D; Drapeau G; Dion S; D'Orléans-Juste P
Life Sci; 1987 Jan; 40(2):109-17. PubMed ID: 2432376
[TBL] [Abstract][Full Text] [Related]
20. Influence of the replacement of amino acid by its D-enantiomer in the sequence of substance P. 1. Binding and pharmacological data.
Duplaa H; Chassaing G; Lavielle S; Beaujouan JC; Torrens Y; Saffroy M; Glowinski J; D'Orléans Juste P; Regoli D; Carruette A
Neuropeptides; 1991 Aug; 19(4):251-7. PubMed ID: 1717876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
